As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the closing of the exclusive global ...

Recombinant antibody technology has helped address many problems associated with hybridoma platforms, opening the door to a ...

Led by former Seagen CEO David Epstein, the startup claims it has a drug that could stand out from other PD1- and ...

Ocular MG is marked by lower AChR antibody titers and a milder phenotype, and responds more quickly to less aggressive ...

Knowing your blood type is more important than you think. Here's why and tips for finding yours before an emergency happens.

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab, a monoclonal antibody in ...

Oruka Therapeutics, Inc. ("Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new ...

By Charles Buchanan For people living with autoimmune diseases, their condition can cast a constant shadow over nearly every ...

Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the one of the biggest problems with ...

Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the ...

Viridian's veligrotug shows promising results in treating TED patients, setting the stage for future growth in the ...